AstraZeneca and Harvard Partner on Stem Cell Therapies for Diabetes – Genetic Engineering & Biotechnology News
|
AstraZeneca and Harvard Partner on Stem Cell Therapies for Diabetes
Genetic Engineering & Biotechnology News AstraZeneca entered into a five-year research collaboration with the Harvard Stem Cell Institute (HSCI) to adapt a technique that creates human beta cells from stem cells for use in screens of AstraZeneca's compound library in the search for new … Stem Cell Therapy Promising for Type 2 Diabetes |
